| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14728220902806444 |
| P698 | PubMed publication ID | 19335067 |
| P50 | author | Rolf Bjerkvig | Q55223218 |
| Simone P Niclou | Q56167031 | ||
| Hrvoje Miletic | Q92993578 | ||
| P2093 | author name string | Mikael Johansson | |
| P2860 | cites work | Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma | Q28286168 |
| P433 | issue | 4 | |
| P304 | page(s) | 455-468 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms | |
| P478 | volume | 13 |
| Q34621127 | Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma |
| Q37613594 | Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma |
| Q37877409 | Anti-angiogenic therapy in glioma |
| Q34718047 | Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis |
| Q39595054 | Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells. |
| Q36787777 | Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges. |
| Q42576930 | Brain cancer stem cells: current status on glioblastoma multiforme |
| Q48124224 | Chronic arterial hypertension impedes glioma growth: a multiparametric MRI study in the rat. |
| Q36500372 | Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy |
| Q38967004 | Direct effect of bevacizumab on glioblastoma cell lines in vitro |
| Q48014727 | EGFR heterogeneity and implications for therapeutic intervention in glioblastoma |
| Q36523864 | Efficacy and safety of bevacizumab for the treatment of glioblastoma. |
| Q37494827 | Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling |
| Q35914515 | Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion |
| Q38160735 | Glioblastoma-initiating cells: relationship with neural stem cells and the micro-environment |
| Q89127042 | High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment |
| Q46960662 | Impact of VEGFA polymorphisms on glioma risk in Chinese |
| Q90266681 | MicroRNA‑576‑3p inhibits the migration and proangiogenic abilities of hypoxia‑treated glioma cells through hypoxia‑inducible factor‑1α |
| Q33911283 | Molecular targeting of glioblastoma: Drug discovery and therapies |
| Q38822001 | Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma. |
| Q46066009 | Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI. |
| Q33414370 | Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus |
| Q33965491 | Potential therapeutic implications of cancer stem cells in glioblastoma |
| Q42120982 | Targeted antiepidermal growth factor receptor (cetuximab) immunoliposomes enhance cellular uptake in vitro and exhibit increased accumulation in an intracranial model of glioblastoma multiforme. |
| Q37869437 | Targeted therapy in pediatric and adolescent oncology |
| Q36526512 | The VEGF pathway in cancer and disease: responses, resistance, and the path forward. |
| Q41364759 | The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells |
| Q35101452 | Understanding dynamic changes in live cell adhesion with neutron reflectometry |
| Q36127410 | VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling |
| Q28567903 | Vascular endothelial growth factor participates in modulating the C6 glioma-induced migration of rat bone marrow-derived mesenchymal stem cells and upregulates their vascular cell adhesion molecule-1 expression |
| Q34268162 | Vascular-targeted photothermal therapy of an orthotopic murine glioma model. |
| Q30428632 | XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC. |
| Q37592046 | microRNAs in gliomas: small regulators of a big problem |
Search more.